Literature DB >> 1446891

The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion.

P B Mortensen1.   

Abstract

The influence of lactulose on organic acid fermentation, nitrogen metabolism and excretion in the colon associated with its mechanism of action on hepatic encephalopathy was investigated. Orally administered lactulose in increasing amounts (0 to 20 to 40 to 80 to 160 gm/day) to 12 healthy volunteers decreased ammonia production in 16.6% fecal homogenates incubated 6 hr and 24 hr at 37 degrees C (mean +/- S.E.M.: from 7 +/- 1 to 0 +/- 0 and from 13 +/- 2 to 0 +/- 0 mmol/L, respectively). Every dose of lactulose was given for 3 days with intervals of 1 to 2 wk, and 24-hr stools were collected on day 3. Fecal concentrations of ammonia decreased (from 50 +/- 9 to 11 +/- 3 mmol/L), but ammonia excretions increased (from 6 +/- 2 to 17 +/- 4 mmol/24 hr). Total fecal concentrations of nitrogen decreased (from 1,043 +/- 78 to 300 +/- 136 mmol/L), but excretions of nitrogen increased fourfold (from 111 +/- 21 to 457 +/- 113 mmoL/24 hr) because of the increase in stool mass. Fecal pH declined (from 6.9 +/- 0.1 to 4.9 +/- 0.1), but total organic acids (short-chain fatty acids and DL-lactate; range = 105 to 148 mmol/L) and osmolality in feces (417 to 450 mOsm/L) did not change, although the colonic fermentation of lactulose had a major impact on the proportions between the nontoxic acetate (increased from 65% +/- 2% to 89% +/- 3%) and the potentially neurotoxic 3-6-carbon fatty acids (decreased from 35% +/- 2% to 11% +/- 2%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446891     DOI: 10.1002/hep.1840160608

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

Review 1.  Pathophysiology, diagnosis, and management of hepatic encephalopathy.

Authors:  Christopher Sheasgreen; Lucy Lu; Ameen Patel
Journal:  Inflammopharmacology       Date:  2014-10-10       Impact factor: 4.473

2.  Increasing the intestinal resistance of rats to the invasive pathogen Salmonella enteritidis: additive effects of dietary lactulose and calcium.

Authors:  I M Bovee-Oudenhoven; D S Termont; P J Heidt; R Van der Meer
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 3.  Lactulose, disaccharides and colonic flora. Clinical consequences.

Authors:  M R Clausen; P B Mortensen
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

4.  Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.

Authors:  H Miyaji; S Ito; T Azuma; Y Ito; Y Yamazaki; Y Ohtaki; F Sato; M Hirai; M Kuriyama; Y Kohli
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

5.  Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence.

Authors:  Steven L Flamm
Journal:  Therap Adv Gastroenterol       Date:  2011-05       Impact factor: 4.409

Review 6.  Novel Drugs for the Management of Hepatic Encephalopathy: Still a Long Journey to Travel.

Authors:  Siddheesh Rajpurohit; Balaji Musunuri; Pooja Basthi Mohan; Shiran Shetty
Journal:  J Clin Exp Hepatol       Date:  2022-01-31

Review 7.  Applications of inulin and oligofructose in health and nutrition.

Authors:  Narinder Kaur; Anil K Gupta
Journal:  J Biosci       Date:  2002-12       Impact factor: 1.826

8.  Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity.

Authors:  Laura E Halpin; Nicole A Northrop; Bryan K Yamamoto
Journal:  Neuropsychopharmacology       Date:  2013-10-29       Impact factor: 7.853

9.  Functional genetics of human gut commensal Bacteroides thetaiotaomicron reveals metabolic requirements for growth across environments.

Authors:  Hualan Liu; Anthony L Shiver; Morgan N Price; Hans K Carlson; Valentine V Trotter; Yan Chen; Veronica Escalante; Jayashree Ray; Kelsey E Hern; Christopher J Petzold; Peter J Turnbaugh; Kerwyn Casey Huang; Adam P Arkin; Adam M Deutschbauer
Journal:  Cell Rep       Date:  2021-03-02       Impact factor: 9.423

Review 10.  Hepatic encephalopathy.

Authors:  Wissam Bleibel; Abdullah M S Al-Osaimi
Journal:  Saudi J Gastroenterol       Date:  2012 Sep-Oct       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.